The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach a value of USD 17,335.8 Million. The rare inflammatory disease treatment market has been garnering significant attention within the healthcare sector …